67 related articles for article (PubMed ID: 22370791)
21. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
22. Preparation and evaluation of bioadhesive dibucaine gels for enhanced local anesthetic action.
Kang C; Shin SC
Arch Pharm Res; 2010 Aug; 33(8):1277-83. PubMed ID: 20803132
[TBL] [Abstract][Full Text] [Related]
23. Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain.
Ved PM; Kim K
Int J Pharm; 2011 Jun; 411(1-2):1-9. PubMed ID: 21356294
[TBL] [Abstract][Full Text] [Related]
24. Development and
Wang D; Du Y; Zhang W; Han X; Zhang H; Wang Z; Liu N; Li M; Gao X; Zhuang X; Gao J; Zheng A
Drug Deliv; 2021 Dec; 28(1):487-498. PubMed ID: 33657948
[TBL] [Abstract][Full Text] [Related]
25. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
[TBL] [Abstract][Full Text] [Related]
26. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
27. The impact of DeltaG on the oral bioavailability of low bioavailable therapeutic agents.
Salama NN; Fasano A; Thakar M; Eddington ND
J Pharmacol Exp Ther; 2005 Jan; 312(1):199-205. PubMed ID: 15448170
[TBL] [Abstract][Full Text] [Related]
28. Recent progress in protein and peptide delivery by noninvasive routes.
Wearley LL
Crit Rev Ther Drug Carrier Syst; 1991; 8(4):331-94. PubMed ID: 1769066
[TBL] [Abstract][Full Text] [Related]
29. Formulation and evaluation of ubidecarenone transdermal delivery systems.
Jung SY; Kang EY; Choi YJ; Chun IK; Lee BK; Gwak HS
Drug Dev Ind Pharm; 2009 Sep; 35(9):1029-34. PubMed ID: 19365779
[TBL] [Abstract][Full Text] [Related]
30. Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers.
Paudel KS; Hammell DC; Agu RU; Valiveti S; Stinchcomb AL
Drug Dev Ind Pharm; 2010 Sep; 36(9):1088-97. PubMed ID: 20545522
[TBL] [Abstract][Full Text] [Related]
31. A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis.
Boirivant M; Amendola A; Butera A; Sanchez M; Xu L; Marinaro M; Kitani A; Di Giacinto C; Strober W; Fuss IJ
Gastroenterology; 2008 Nov; 135(5):1612-1623.e5. PubMed ID: 18765239
[TBL] [Abstract][Full Text] [Related]
32. Oxprenolol-loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization.
Preda M; Leucuta SE
J Microencapsul; 2003; 20(6):777-89. PubMed ID: 14594666
[TBL] [Abstract][Full Text] [Related]
33. Intestinal paracellular permeation enhancement with quaternised chitosan: in situ and in vitro evaluation.
Jonker C; Hamman JH; Kotzé AF
Int J Pharm; 2002 May; 238(1-2):205-13. PubMed ID: 11996824
[TBL] [Abstract][Full Text] [Related]
34. The ethanol metabolite acetaldehyde increases paracellular drug permeability in vitro and oral bioavailability in vivo.
Fisher SJ; Swaan PW; Eddington ND
J Pharmacol Exp Ther; 2010 Jan; 332(1):326-33. PubMed ID: 19820208
[TBL] [Abstract][Full Text] [Related]
35. Improved paracellular uptake by the combination of different types of permeation enhancers.
Guggi D; Bernkop-Schnürch A
Int J Pharm; 2005 Jan; 288(1):141-50. PubMed ID: 15607266
[TBL] [Abstract][Full Text] [Related]
36. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
Krauland AH; Guggi D; Bernkop-Schnürch A
Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914
[TBL] [Abstract][Full Text] [Related]
37. Effect of lactic acid and iontophoresis on drug permeation across rabbit ear skin.
Sebastiani P; Nicoli S; Santi P
Int J Pharm; 2005 Mar; 292(1-2):119-26. PubMed ID: 15725558
[TBL] [Abstract][Full Text] [Related]
38. Development of valsartan-loaded gelatin microcapsule without crystal change using hydroxypropylmethylcellulose as a stabilizer.
Li DX; Yan YD; Oh DH; Yang KY; Seo YG; Kim JO; Kim YI; Yong CS; Choi HG
Drug Deliv; 2010 Jul; 17(5):322-9. PubMed ID: 20367177
[TBL] [Abstract][Full Text] [Related]
39. Intestinal permeation enhancers.
Aungst BJ
J Pharm Sci; 2000 Apr; 89(4):429-42. PubMed ID: 10737905
[TBL] [Abstract][Full Text] [Related]
40. New strategies to improve the intranasal absorption of insulin.
Duan X; Mao S
Drug Discov Today; 2010 Jun; 15(11-12):416-27. PubMed ID: 20359545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
